Form 4: Calumet Director Jennifer Straumins Granted 7,067 Restricted Stock Units

Calumet, Inc. Director Jennifer Straumins was granted 7,067 Restricted Stock Units, which are scheduled to vest by June 2026.

Summary

• Jennifer Straumins, a Director of Calumet, Inc. (CLMT), was granted 7,067 Restricted Stock Units (RSUs) on June 11, 2025.
• Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.
• The RSUs were granted at a price of $0, which is typical for equity compensation.
• Following this transaction, Ms. Straumins directly beneficially owns 7,067 Restricted Stock Units.
• The Restricted Stock Units are scheduled to vest upon the earlier of June 11, 2026, or the date on which Calumet, Inc. holds its Annual Meeting in 2026.
• Upon vesting, the Restricted Stock Units will be settled.

Sentiment

Score: 7

Explanation: The grant of equity compensation to a director is a positive step for corporate governance, aligning the director's interests with long-term shareholder value. It is a routine transaction, not indicative of significant operational changes or financial distress.

Positives

• The grant of 7,067 Restricted Stock Units to Director Jennifer Straumins aligns her interests with those of shareholders, incentivizing long-term performance and commitment to the company's success.

Negatives

• No specific negative aspects are identified in this standard equity grant filing.

Risks

• The document, a Form 4, does not detail specific company risks. However, the ultimate value of the granted Restricted Stock Units is subject to the future performance and stock price of Calumet, Inc., which carries inherent market risks.

Future Outlook

The Restricted Stock Units are forward-looking compensation, designed to vest upon the earlier of June 11, 2026, or the date of Calumet, Inc.'s Annual Meeting in 2026, aligning future compensation with company performance and long-term strategic goals.

Management Comments

• This Form 4 filing is a regulatory disclosure of an insider transaction and does not contain direct management comments or quotes.

Industry Context

The grant of Restricted Stock Units to a director is a common and widely accepted practice in corporate governance across various industries, including specialty chemicals and lubricants, used to align the interests of board members with long-term shareholder value creation and retention.

Comparison to Industry Standards

• The grant of Restricted Stock Units is a standard form of equity compensation for directors in publicly traded companies. While the specific number of units (7,067) is unique to this individual and company, the mechanism of granting time-based equity is consistent with compensation practices observed in comparable companies within the specialty chemicals and lubricants industry. Without specific compensation benchmarks for Calumet's peer group, a direct quantitative comparison of the grant size is not feasible from this document alone.

Management Changes

Corporate Governance

Related Party Transactions

• The grant of 7,067 Restricted Stock Units to Jennifer Straumins, a Director of Calumet, Inc., constitutes a transaction with a related party (insider compensation).

Stakeholder Impact

• Shareholders: The grant of equity compensation to a director aims to align their interests with long-term shareholder value creation, potentially leading to improved governance and performance.
• Employees: No direct impact on employees is indicated by this filing, as it pertains to director compensation.

Next Steps

• The Restricted Stock Units will vest upon the earlier of June 11, 2026, or the date of Calumet, Inc.'s Annual Meeting in 2026.
• Upon vesting, the Restricted Stock Units will be settled into common stock.

Key Dates

Keywords

Calumet Inc., CLMT, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, SEC Form 4, Equity Grant, Jennifer Straumins